Ajmaline infusion during automated screening in Brugada syndrome and spontaneous Type 1 electrocardiogram unmasks non-suitability for subcutaneous implantable cardioverter-defibrillator
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.